Julianne is an accomplished CFO, audit committee chair, and commercial growth leader with 20+ years of experience leading life science, digital health, and techbio companies through scale and transformation. She has guided the close of billions of dollars through capital raises, M&A transactions, and IPOs.

Julianne currently serves as a board member and audit committee chair for Biomea Fusion and CureSearch for Children’s Cancer. Her previous roles include CFO and CBO at Alveo Technologies, VP of Finance at BlackThorn Therapeutics, and Associate VP of Finance & Accounting at Manifest MedEx.

Julianne holds MS and BS degrees in Accounting and Business Administration from California State University.

Select Accomplishments

• Led AI-enabled therapeutics organization through dual track of IPO planning and M&A process, resulting in completion of complex merger transaction valued at over $2B.
• Established BD team that closed over five major US and international collaboration/distribution/grant deals in a six-month period, establishing a medtech company’s initial product revenue and distribution channels.